Want to join the conversation?
$CCE said that currency translation would negatively impact 1Q16 diluted EPS by 5% & expects 2016 free cash flow to be between $500-550MM after expected CCEP transaction cash cost of $75MM-100MM. CapEx is expected to be approx. $325MM. Given the pending transaction, $CCE does not expect to repurchase shares in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?